Rob Taub is not only a respected figure in film, radio, television, and journalism but also an advocate for type 2 diabetes and ambassador for a joint venture between the American Heart Association and American Diabetes Association called Know Diabetes By

Nearly half of the adult U.S. population suffers from some form of periodontal disease, which can result in the rapid destruction or slow reduction of bone, inflamed soft tissues, abscesses, and tooth loss. In the past, bone grafting—a procedure which is

Over the past few years, organoid research and development has expanded tremendously; perhaps one of the best experts on the topic is Robert Vries, PhD, who contributed to the first-time published organoid technology in 2009. As the CEO of Hubrecht...

In recent years, interest in organoid technology has exploded. More than ever before, scientists, researchers, and the public at large are beginning to appreciate the value that organoids can contribute to the understanding and clinical treatment of disea

In an effort to both improve current artificial intelligence (AI) models and our understanding of the brain, Associate Professor in the Computer Science and Operations Research Department at the University of Montreal, Irina Rish, PhD is studying a...

Associate Professor in the Computer Science and Operations Research Department at the University of Montreal, Irina Rish, PhD focuses her work on the intersection between artificial intelligence (AI) and neuroscience, researching

Eduard Willms, Postdoctoral Scientist, La Trobe University, Australia, discusses the (EVs), the role of extracellular vesicles, and the research that could provide new avenues for efficient drug and therapeutic delivery. Willms earned his BSc in...

Eduard Willms, Postdoctoral Scientist at La Trobe University, Melbourne, Australia, provides an overview of the types of extracellular vesicles, and the role of extracellular vesicles (EVs).Willms research is focused on the role of extracellular vesicles

Not more than twenty years ago, only four or five blood cancers could be defined; today, hundreds of different types of lymphoma, leukemia, and myeloma cancers have been characterized—each one with a unique molecular structure and genome. As a result

“The premise of Lantern is to use the most current advances in machine learning, artificial intelligence, and  to help rescue and develop cancer drugs faster and cheaper and with lower risk so we can get them to patients in a more...